(August 26, 2025) – TheNewswire - Femto Technologies Inc. (OTCID: FMTOF) (“Femto” or the “Company”), a pioneering femtech company has released its financial results for six-month ended June 30, 2025. Full versions of Femto’s unaudited consolidated interim financial statements and management discussion and analysis for the period, can be found on www.sedarplus.ca.

 

Q2 2025 Financial and Business Highlights:

 

• Revenue decreased 43% to $407,921 for the six-month period ended June 30, 2025, from $714,914 for the same period in 2024. 

• Gross Profit decreased to 9% for the six-month period ended June 30, 2025, from 25% for the same period in 2024. 

• Net Income was $21,106,751 for the six-month period ended June 30, 2025 compared with a net loss of $30,539,942 for the same period in 2024. 

• Working capital increased to 18,465,571 for June 30, 2025, from $4,121,747 for December 31,2024. 

• Total assets increased to $44,469,942 for June 30, 2025, from $30,241,067 for December 31,2024. 

• Income per share was $58.57 for the six-month period ended June 30, 2025 from a loss of $54,232 for the same period in 2024. 

• Total shares outstanding as of June 30, 2025, were 840,762. 

        

Summary of Quarterly Comparison of Revenue, Gross Profit and Net Loss

 

	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Revenue	$205,229	$202,692	$182,306	$101,619	$405,946	$308,968	$205,121	$202,058
Gross Profit (loss)	$19,728	$14,985	$65,221	$(91,777)	$111,308	$65,950	$(56,711)	$72,085
Net Profit (loss)	$31,784,170	$(10,677,419)	$(11,631,845)	$(5,418,470)	$77,375	$(30,617,317)	$(15,167,579)	$(1,439,785)

  

Mr. Yftah Ben Yaackov, Femto’s CEO noted that “Despite the fact that the company was delisted from Nasdaq, we are waiting for Nasdaq’s listing and hearing review council’s decision regarding the appeal we have submitted and are hopeful for a positive decision. We are continuing in full strength to bring the Sensera product to the market despite all the challenges we encountered on the way. We believe that we have the knowledge and technology required to bring to the market high-quality products that will make a significant difference.”

  

About Femto Technologies Inc.

 

Femto Technologies Inc. (OTCID: FMTOF) is a cutting-edge femtech company spearheading transformative advancements in wellness technology. With a strong emphasis on AI-driven solutions, Femto is dedicated to innovating products that enhance well-being through intelligent technology integration.

 

ABOUT SENSERA

Sensera is a feminine wellness device designed to bridge the gap between feminine pleasure and wellness, providing a holistic self-care experience that adapts to a woman’s changing needs. Sensera utilizes Femto’s proprietary Smart Release System (SRS) technology, including machine learning and AI, to enhance feminine wellness. Sensera is a CES Innovation Awards® 2025 Honorary in the AI category.

For more information on Sensera, please visit www.senserawellness.com and follow us on Instagram, Facebook, and YouTube.

 

MEDIA CONTACT

For product demonstration and media

Samantha Breen

Opportunity PR (for Sensera)

samantha@opportunitypr.com

+1 949.290.2834

 

COMPANY CONTACT

Gabi Kabazo

Chief Financial Officer

Tel: (604) 833-6820

e‐mail: ir@femtocorp.com

 

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain statements that may be deemed “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this press release, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward‐looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.

Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2024 and annual information form dated March 31, 2025, which are available under the company's profile at www.sedarplus.ca, and in the Company’s Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on March 31, 2025. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward‐looking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward‐looking statements.